BeStock  
股票 › 生物科技 › NTLA

因特利亚制药 NTLA

美股市值排名 #2900生物科技基因编辑
$11.35 +$0.25 (+2.25%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $11.39 +0.34%
开盘$11.26
昨收$11.10
当日区间$11.02 – $11.40
成交量4.40M
市值$1.59B
市盈率(TTM)–
股息率–

基本面

最新报告季度:Q2, ended Jun 2026

营收$7.66M-46.2% YoY
营业利润-$112.76M-2.5% YoY
净利润-$106.63M-5.3% YoY
摊薄每股收益-$0.80+18.4% YoY
自由现金流-$84.92M+15.0% YoY
经营现金流-$83.11M

营收,近8个季度

$9.1MSep '24$12.9MDec '24$16.6MMar '25$14.2MJun '25$13.8MSep '25$23.0MDec '25$15.0MMar '26$7.7MJun '26

净利润,近8个季度

$-135.7MSep '24$-128.9MDec '24$-114.3MMar '25$-101.3MJun '25$-101.3MSep '25$-95.8MDec '25$-96.2MMar '26$-106.6MJun '26

各季度摊薄每股收益

-1.34Sep '24-1.27Dec '24-1.10Mar '25-0.98Jun '25-0.92Sep '25-0.83Dec '25-0.81Mar '26-0.80Jun '26

各季度自由现金流

$-86.1MSep '24$-86.2MDec '24$-149.7MMar '25$-99.9MJun '25$-76.9MSep '25$-69.4MDec '25$-117.4MMar '26$-84.9MJun '26

年度营收

$58.0MFY20$33.1MFY21$52.1MFY22$36.3MFY23$57.9MFY24$67.7MFY25

盈利能力与资产负债表

营业利润率-711.7%
净利率-672.2%
净资产收益率-55.4%
资产收益率-45.6%
投入资本回报率-52.4%
流动比率6.65
负债/资产比率15.1%
现金及投资$437.76M
总负债$50.07M
净现金(净负债)$387.69M

利润表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
报告营业总收入 $7.66M $15.05M $67.67M $23.02M $13.78M
营业总收入 $7.66M $15.05M $67.67M $23.02M $13.78M
营业费用 $120.42M $115.58M $508.66M $121.73M $125.26M
销售及管理费用 $37.82M $34.84M $119.80M $33.08M $30.51M
-管理费用 $37.82M $34.84M $119.80M $33.08M $30.51M
研发费用 $82.60M $80.74M $388.86M $88.65M $94.75M
营业利润 -$112.76M -$100.53M -$440.99M -$98.71M -$111.48M
非经营性利息净收入(支出) $5.80M $5.21M $29.20M $6.48M $6.71M
非经营性利息收入 $5.80M $5.21M $29.20M $6.48M $6.71M
其他收入(支出) $329,000.00 -$904,000.00 -$899,000.00 -$3.55M $3.44M
证券出售收益 $329,000.00 -$904,000.00 -$899,000.00 -$3.55M $3.44M
税前利润 -$106.63M -$96.23M -$412.69M -$95.79M -$101.32M
净利润 -$106.63M -$96.23M -$412.69M -$95.79M -$101.32M
持续经营利润 -$106.63M -$96.23M -$412.69M -$95.79M -$101.32M
归属母公司净利润 -$106.63M -$96.23M -$412.69M -$95.79M -$101.32M
归属普通股股东净利润 -$106.63M -$96.23M -$412.69M -$95.79M -$101.32M
基本每股收益 -$0.80 -$0.81 -$3.81 -$0.83 -$0.92
摊薄每股收益 -$0.80 -$0.81 -$3.81 -$0.83 -$0.92
权益法投资收益 – – $0.00 – –
特殊收益(费用) – – $0.00 – –
-减:重组及并购费用 – – $0.00 – –

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
总资产 $857.16M $758.78M $842.13M $842.13M $925.28M
流动资产合计 $527.83M $466.45M $527.71M $527.71M $581.94M
现金及现金等价物与短期投资 $437.76M $375.99M $449.88M $449.88M $511.04M
-现金及现金等价物 $106.13M $134.70M $155.46M $155.46M $193.39M
-短期投资 $331.63M $241.29M $294.42M $294.42M $317.66M
应收款 $7.32M $9.13M $9.47M $9.47M $11.05M
-应收账款 $7.32M $9.13M $9.47M $9.47M $11.05M
其他流动资产 $82.75M $81.33M $68.36M $68.36M $59.85M
非流动资产合计 $329.33M $292.33M $314.42M $314.42M $343.33M
固定资产净值 $101.01M $113.06M $123.63M $123.63M $138.30M
-固定资产原值 $101.01M $113.06M $182.23M $182.23M $138.30M
投资及预付款 $212.48M $162.82M $190.79M $190.79M $188.34M
-可供出售证券 $190.60M $141.26M $155.25M $155.25M $158.81M
其他非流动资产 $15.84M $16.46M – – $16.69M
负债合计 $129.46M $137.84M $170.73M $170.73M $176.85M
流动负债合计 $79.39M $76.45M $103.88M $103.88M $93.73M
应付款 $11.71M $18.80M $20.25M $20.25M $13.26M
-应付账款 $11.71M $18.80M $20.25M $20.25M $13.26M
一年内应计费用 $29.91M $28.60M $26.79M $26.79M $24.01M
短期债务及融资租赁负债 $23.34M $19.10M $26.48M $26.48M $27.38M
-一年内到期融资租赁负债 $23.34M $19.10M $26.48M $26.48M $27.38M
一年内递延负债 $0.00 $630,000.00 $7.29M $7.29M $12.25M
非流动负债合计 $50.07M $61.40M $66.85M $66.85M $83.13M
长期债务及融资租赁负债 $50.07M $61.40M $66.85M $66.85M $70.59M
-长期融资租赁负债 $50.07M $61.40M $66.85M $66.85M $70.59M
股东权益合计 $727.71M $620.94M $671.39M $671.39M $748.42M
股东权益 $727.71M $620.94M $671.39M $671.39M $748.42M
股本 $14,000.00 $12,000.00 $12,000.00 $12,000.00 $12,000.00
-普通股 $14,000.00 $12,000.00 $12,000.00 $12,000.00 $12,000.00
资本公积 $3.52B $3.31B $3.26B $3.26B $3.24B
留存收益 -$2.79B -$2.69B -$2.59B -$2.59B -$2.49B
不影响留存收益的损益 -$1.03M -$240,000.00 $1.03M $1.03M $990,000.00
-累计折旧 – – -$58.61M -$58.61M –
一年以上递延负债 – – $0.00 $0.00 $12.54M

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
经营活动现金流 -$83.11M -$117.35M -$394.74M -$69.29M -$76.90M
持续经营经营活动现金流净额 -$83.11M -$117.35M -$394.74M -$69.29M -$76.90M
持续经营净利润 -$106.63M -$96.23M -$412.69M -$95.79M -$101.32M
折旧、折耗与摊销 $2.08M $2.20M $15.92M $6.02M $4.94M
营运资金变动 $4.15M -$37.17M -$73.75M $494,000.00 $4.41M
-应收款变动 $1.81M $337,000.00 -$951,000.00 $1.58M $303,000.00
-预付资产变动 -$1.42M -$12.97M -$26.35M -$8.69M -$23.04M
-应付账款及应计费用变动 -$730,000.00 -$13.37M $716,000.00 $15.99M $2.74M
-其他流动资产变动 $10.12M $8.34M $35.90M $10.23M $33.93M
-其他流动负债变动 -$5.00M -$12.84M -$54.95M -$4.64M -$4.63M
-其他营运资金变动 -$630,000.00 -$6.66M -$28.11M -$13.98M -$4.91M
投资活动现金流净额 -$141.57M $66.31M $228.03M $27.53M -$741,000.00
持续经营投资活动现金流净额 -$141.57M $66.31M $228.03M $27.53M -$741,000.00
固定资产购置及出售净额 -$1.72M -$79,000.00 -$1.13M -$126,000.00 -$29,000.00
投资购置及出售净额 -$139.85M $66.39M $229.16M $27.66M -$712,000.00
筹资活动现金流 $196.12M $33.57M $131.49M $1.98M $114.86M
持续经营筹资活动现金流净额 $196.12M $33.57M $131.49M $1.98M $114.86M
普通股发行净额 $194.58M $33.57M $128.18M $0.00 $114.76M
期末现金余额 $121.53M $150.10M $167.57M $167.57M $207.34M
现金净变动 -$28.57M -$17.47M -$35.22M -$39.77M $37.22M
期初现金余额 $150.10M $167.57M $202.79M $207.34M $170.13M
自由现金流 -$84.92M -$117.43M -$395.87M -$69.41M -$76.93M
持续经营损益 – – $527,000.00 – –
股票期权行使所得 – – $3.31M $1.98M $97,000.00

讨论区

暂无评论——快来第一个聊聊 NTLA。

发表评论

Scroll to Top